AGLE · Categories · Form 4

AGLE - SEC Form 4 insider transactions

Aeglea BioTherapeutics Inc. (AGLE) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for AGLE

• 849d
  SEC Form 4 filed by Mckenna Mark C.

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 852d
  SEC Form 4 filed by Turtle Cameron

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 852d
  SEC Form 4 filed by Burrows Scott L

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 852d
  SEC Form 4 filed by King-Jones Heidy

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 887d
  Fairmount Funds Management Llc disposed of 3,435,480 shares and acquired 812,076 shares (SEC Form 4)

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 894d
  Burrows Scott L was granted 134,953 shares (SEC Form 4)

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 905d
  SEC Form 4 filed by Fairmount Funds Management Llc

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 908d
  Albers Jeffrey W. converted options into 34,360 shares (SEC Form 4) (Amendment)

  4/A - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 918d
  Fairmount Funds Management Llc converted options into 3,435,480 shares (SEC Form 4)

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 919d
  SEC Form 4 filed by Albers Jeffrey W.

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 919d
  SEC Form 4 filed by Stelzer Laurie

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 919d
  Turtle Cameron converted options into 723,440 shares, increasing direct ownership by 3,136% to 746,507 units (SEC Form 4)

  4 - Spyre Therapeutics, Inc. (0001636282) (Issuer)
• 1002d
  SEC Form 4 filed by King-Jones Heidy

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1002d
  SEC Form 4 filed by Burrows Scott L

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 4 filed by Alspaugh Jonathan

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 4 filed by Cox Russell J.

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 4 filed by Magovcevic-Liebisch Ivana

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 4 filed by Smith Hunter C

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1069d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1195d
  SEC Form 4 filed by Neuman Linda L

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1195d
  SEC Form 4 filed by Kastenmayer James Paul

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1195d
  SEC Form 4 filed by Hanley Jr. Michael Conick

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1195d
  SEC Form 4 filed by Alspaugh Jonathan

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1223d
  SEC Form 4 filed by Neuman Linda L

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1280d
  SEC Form 4 filed by Goldberg Jeff Marc

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1378d
  SEC Form 4 filed by Kastenmayer James Paul

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1378d
  SEC Form 4: Souza Marcio bought $50,472 worth of shares (90,000 units at $0.56)

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1378d
  SEC Form 4 filed by Sloan Leslie

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1378d
  SEC Form 4 filed by Hanley Jr. Michael Conick

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1378d
  SEC Form 4 filed by Alspaugh Jonathan

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1454d
  SEC Form 4: Hanley Jr. Michael Conick bought $20,022 worth of shares (28,200 units at $0.71), increasing direct ownership by 352% to 36,200 units

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1454d
  SEC Form 4 filed by Lawton Alison Frances

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Shanafelt Armen

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Souza Marcio

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Smith Hunter C

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Mahatme Sandesh

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Magovcevic-Liebisch Ivana

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Lawlis V Bryan

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1455d
  SEC Form 4 filed by Cox Russell J.

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1538d
  SEC Form 4: Quinn Anthony G. bought $187,705 worth of shares (80,079 units at $2.34), increasing direct ownership by 17% to 550,540 units

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1541d
  SEC Form 4: Quinn Anthony G. bought $280,943 worth of shares (144,666 units at $1.94), increasing direct ownership by 44% to 473,461 units

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1541d
  SEC Form 4: Alspaugh Jonathan bought $156,000 worth of shares (75,000 units at $2.08), increasing direct ownership by 83% to 165,372 units

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1562d
  SEC Form 4 filed by Quinn Anthony G.

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1562d
  SEC Form 4 filed by Weber Steven

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1562d
  SEC Form 4 filed by Sloan Leslie

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1562d
  SEC Form 4 filed by Hanley Jr. Michael Conick

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1562d
  SEC Form 4 filed by Alspaugh Jonathan

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1633d
  SEC Form 4: Shanafelt Armen bought $549,692 worth of shares (150,000 units at $3.66)

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1633d
  SEC Form 4: Quinn Anthony G. bought $198,972 worth of shares (53,634 units at $3.71), increasing direct ownership by 19% to 328,795 units

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1633d
  SEC Form 4: Alspaugh Jonathan bought $186,000 worth of shares (50,000 units at $3.72), increasing direct ownership by 124% to 90,372 units

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1660d
  SEC Form 4 filed by Smith Hunter C

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1750d
  SEC Form 4: Alspaugh Jonathan bought $262,660 worth of Common Stock (40,372 units at $6.51)

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1791d
  SEC Form 4 filed by Alspaugh Jonathan

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1807d
  SEC Form 4 filed by Souza Marcio

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1819d
  SEC Form 4 filed by BAKER BROS. ADVISORS LP

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1820d
  SEC Form 4 filed by Shanafelt Armen

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1820d
  SEC Form 4 filed by Aeglea BioTherapeutics, Inc.

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1820d
  SEC Form 4 filed by Mahatme Sandesh

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1820d
  SEC Form 4 filed by Aeglea BioTherapeutics, Inc.

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)
• 1820d
  SEC Form 4 filed by LAWLIS V BRYAN

  4 - Aeglea BioTherapeutics, Inc. (0001636282) (Issuer)

Other AGLE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends